• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Modelling stromal FAK regulation of tumour growth, angiogenesis and progression 
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • Modelling stromal FAK regulation of tumour growth, angiogenesis and progression
    •   QMRO Home
    • Queen Mary University of London Theses
    • Theses
    • Modelling stromal FAK regulation of tumour growth, angiogenesis and progression
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Modelling stromal FAK regulation of tumour growth, angiogenesis and progression

    View/Open
    BATISTAModellingStromal2012.pdf (49.94Mb)
    Publisher
    Queen Mary University of London
    Metadata
    Show full item record
    Abstract
    The growth of tumours within a whole organism depends on the tumour microenvironment. This involves both resident stromal cells, such as endothelial cells and fibroblasts, and also bone marrow derived stromal cells. Integrins and growth factor receptors are known regulators of the tumour stroma. Since focal adhesion kinase (FAK) is a downstream effector of both integrins and growth factor receptors it likely also plays an important role in the regulation of the tumour microenvironment. Using adult mice where FAK is deleted ubiquitously after treatment with tamoxifen my data demonstrate that loss of stromal FAK inhibits tumour growth and angiogenesis but increases metastasis burden in experimental metastasis assays even when the tumour cells themselves still express FAK. Moreover, my data indicate loss of FAK in the bone marrow (BM) compartment and specifically in myeloid cells is sufficient to enhance tumour metastasis in experimental metastasis assays and in a spontaneous tumour model. In contrast loss of bone marrow FAK was not sufficient to affect primary tumour growth or angiogenesis. Taken together these data demonstrate that bone marrow derived FAK plays a significant but differential role in primary tumour growth and metastasis. 4 In a parallel study, I have developed a novel set of transgenic mice to enable us to dissect the mechanism of FAK function in primary tumour growth, metastasis and angiogenesis. I have generated point-mutant FAK knockin-knockout mice where mutant FAK is inducibly expressed (knockin) and endogenous FAK deleted (knockout) in specific cell types in adult mice. Here I show efficient deletion of mouse FAK and expression of FAK 861F mutant in tamoxifen-treated endothelial cells isolated from mice. Importantly the FAK 861F mutation in endothelial cells was sufficient to decrease tumour growth and angiogenesis in vivo suggesting that the FAK-P-Y861 phosphorylation site plays an important role in tumour growth and angiogenesis.
    Authors
    Batista, Silvia
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/3166
    Collections
    • Theses [3321]
    Copyright statements
    The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without the prior written consent of the author
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.